[Polaris Group] Correction of Endorsement Guarantee Disclosure for March 2026
Key facts
- [Polaris Group] Correction of Endorsement Guarantee Disclosure for March 2026
- Polaris Group has issued a correction regarding the endorsement guarantee balance of its subsidiary, LinYung Biotech, for March 2026.
- Source: PR Times
- Date: May 27, 2026
Direct answer
Polaris Group has issued a correction regarding the endorsement guarantee balance of its subsidiary, LinYung Biotech, for March 2026.
- Citation
- [Polaris Group] Correction of Endorsement Guarantee Disclosure for March 2026 (May 27, 2026), PR Times
- Source
- PR Times
- Date
- May 27, 2026
Polaris Group has issued a correction regarding the endorsement guarantee balance of its subsidiary, LinYung Biotech, for March 2026.
📋 Article Processing Timeline
- 📰 Published: May 27, 2026 at 09:00
- 🔍 Collected: May 28, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 19:09 (83h 9m after Collected)
1. Date of occurrence: 2026/05/27
2. Company name: LinYung Biotech Pharmaceutical Co., Ltd.
3. Relationship with the company: Subsidiary
4. Mutual shareholding ratio: Not applicable
5. Reason for occurrence: Correction of the ending balance of endorsement guarantees
6. Corrected information item/report name: Endorsement Guarantee Information Disclosure Table
7. Amount/content/page before correction: Ending balance of endorsement guarantees for March 2026: 570,000
8. Amount/content/page after correction: Ending balance of endorsement guarantees for March 2026: 555,000
9. Countermeasures: Correction implemented
10. Other matters to be stated: None
2. Company name: LinYung Biotech Pharmaceutical Co., Ltd.
3. Relationship with the company: Subsidiary
4. Mutual shareholding ratio: Not applicable
5. Reason for occurrence: Correction of the ending balance of endorsement guarantees
6. Corrected information item/report name: Endorsement Guarantee Information Disclosure Table
7. Amount/content/page before correction: Ending balance of endorsement guarantees for March 2026: 570,000
8. Amount/content/page after correction: Ending balance of endorsement guarantees for March 2026: 555,000
9. Countermeasures: Correction implemented
10. Other matters to be stated: None
FAQ
What is the significance of TWSE disclosures?
It ensures transparency for investors regarding the financial health and operational changes of listed companies.
What are the key facts in this article?
Polaris Group has issued a correction regarding the endorsement guarantee balance of its subsidiary, LinYung Biotech, for March 2026.
What is the direct answer?
Polaris Group has issued a correction regarding the endorsement guarantee balance of its subsidiary, LinYung Biotech, for March 2026.